This study examined whether electronic medicine dispensers (EMDs) can reduce diversion of take-home buprenorphine–naloxone (BNX) in a medium-sized Finnish city. All BNX treated OST patients in Kuopio received their take-home BNX in EMDs for 4months. EMDs’ effect on diversion was investigated using questionnaires completed by patients (n=37) and treatment staff (n=19), by survey at the local needle exchange service and by systematic review of drug screen data from the Kuopio University Hospital. The majority of patients (n=21, 68%) and treatment staff (n=11, 58%) preferred to use EMDs for the safe storage of tablets. Five patients (16%) declared that EMDs had prevented them from diverting BNX. However, EMDs had no detectable effect on the availability or origin of illegal BNX or on the ho…
The effect of an electronic medicine dispenser on diversion of buprenorphine-naloxone—experience from a medium-sized Finnish city
Previous post: BUPRENORPHINE HCL AND NALOXONE HCL (Buprenorphine And Naloxone) Tablet [AvKARE, Inc.]
Next post: Buprenorphine/naloxone: Death in an infant: case report